| 141/222 | US=92 / Biol/Mol McConkey DJ, Bondar V. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: structure and function of the telomere. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 125-44. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TELOMERASE; ALT; TUMORIGENESIS; INSTABILIDADE GENOMICA; ESTABILIDADE CROMOSSOMO; CANCER; ENVELHECIMENTO |
| 142/222 | US=92 / Biol/Mol Ramirez RD. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: overview of senescence. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 145-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. SENESCENCIA CELULAR; ENVELHECIMENTO; TELOMEROS; TELOMERASE; ALTERNATIVA PARA ALONGAR OS TELOMEROS; PROBLEMA DE REPLICACAO FINAL |
| 143/222 | US=92 / Biol/Mol Possemato R, Hahn WC. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: contributions of telomerase to tumorigenesis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 159-71. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TRANSCRIPTASE REVERSA DA TELOMERASE; TELOMERO; TUMORIGENESIS; TRANSFORMACAO; CANCER |
| 144/222 | US=92 / Biol/Mol Murnane JP. Telomeres and telomerase, senescence, genomic instabilidade, and tumorigenesis: the role of telomeres in genomic instability. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 173-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. AMPLIFICACAO; FUSAO CROMOSSOMICA; ELIMINACAO; DUPLICACAO; INSTABILIDADE GENOMICA; ISOCHROMOSOME; TELOMERO; TRANSLOCACAO |
| 145/222 | US=92 / Biol/Mol Dupré A, Gautier J. DNA damage response, signalling pathways, and tumorigenesis: overview of the DNA damage checkpoint. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 193-221. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ATM; ATR; CHECKPOINTS; REPLICA; CADEIA SIMPLES DE DNA; REPARO DE QUEBRA DE DUPLA FITA DO DNA |
| 146/222 | US=92 / Biol/Mol Maclean KH, Cleveland JL. DNA damage response, signalling pathways, and tumorigenesis: interactions between Myc- and cyclin-dependent kinase inhibitors in cancer. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 223-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 147/222 | US=92 / Biol/Mol Chronis F, Ragakou EP. DNA damage response, signalling pathways, and tumorigenesis: interplay between yH2AX and 53BP1 pathways in DNA double-strand break repair response. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 243-63. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. H2AX; 53BP1; REPARO DE DNA; QUEBRAS DE DUPLA VERTENTE; CROMATINA |
| 148/222 | US=92 / Biol/Mol Povirk LF. DNA damage response, signalling pathways, and tumorigenesis: DNA-dependent protein kinase in repair, apoptosis, telomere maintenance, and chemotherapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 265-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ACABAR JUNTANDO RADIACAO; RUPTURAS DE FILAMENTOS DUPLOS; REPARO DO DNA; KU; ARTEMIS; REPARACAO FOCOS |
| 149/222 | US=92 / Biol/Mol Dent P, Curiel DT, Fisher PB. Resistance and sensitization: resistance/signaling pathways. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 281-98. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. RADIACAO; SINALIZACAO; QUINASE; FOSFATASE; ESPECIES REATIVAS DE OXIGENIO / NITROGENIO; RECEPTOR |
| 150/222 | US=92 / Biol/Mol Cabot MC. Resistance and sensitization: ceramide and multidrug resistance. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 299-312. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. CERAMIDA; QUIMIOTERAPIA; MULTIRRESISTENCIA; GLICOSILCERAMIDA SINTETASE |
| 151/222 | US=92 / Biol/Mol Smith DL, Nolden LK, Mills GB, Lu Y. Resistance and sensitization: chemo-and radiosensitization through inhibition of PI3K/Akt signaling. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 313-34. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. FOSFATIDILINOSITOL 3-QUINASE; AKT; SIGNALTRANSDUCTION; TERAPIA ALVO MOLECULAR; QUIMIOSSENSIBILIZACAO; RADIOSSENSIBILIZACAO |
| 152/222 | US=92 / Biol/Mol Allen GW, Harari PM. Resistance and sensitization: the advancement of epidermal growth factor receptor inhibitors in cancer therapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 335-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RADIACAO; APOPTOSE; INIBIDORES DE MOLECULAS PEQUENAS; ANTICORPOS MONOCLONAIS |
| 153/222 | US=92 / Biol/Mol Houghton JA. Established cancer therapies: antimetabolites. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 361-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ANTIMETABOLITES; MORTE CELULAR; APOPTOSE; CATASTROFE MITOTICA; NECRESIS; SENESCENCIA |
| 154/222 | US=92 / Biol/Mol Sordet O, Pommier Y, Solary E. Established cancer therapies: topoisomerase I poisons and apoptotic topoisomerase I-DNA complexes. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 383-406. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 155/222 | US=92 / Biol/Mol Larsen AK, Skladanowski A. Established cancer therapies: perturbations of cellular functions by topoisomerase II inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 407-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TOPOISOMERASE II; AGENTES ANTICANCERIGENOS; DOXORRUBICINA; ETOPOSIDE; MORTE CELULAR; PARADA DO CRESCIMENTO; APOPTOSE; NECROSE; CATASTRIOHE MITOTICO; INDUZIDA POR DROGAS PSEUDOSENESCENCE; AUTOFAGIA |
| 156/222 | US=92 / Biol/Mol Woynarowski JM, Woynarowska BA. Established cancer therapies: the significance of poly-targeting in apoptosis induction by alkylating agents and platinum drugs. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 423-63. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. DNA DO ADULTO; DROGAS ALQUILACAO; DROGAS PLATIUM; ALQUILACAO DE PROTEINAS; TADGETING PROTEINA; REGULACAO REDOX |
| 157/222 | US=92 / Biol/Mol Klein LE, Horwitz SB. Established cancer therapies: contributions of apoptosis ana senescence to cytotoxicity produced by microtubule-stabilizing agents. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 465-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TAXOL; DISCODERMOLIDE; MICROTUBULOS ACELEROU A SENESCENCIA; AGENTES ESTABILIZADORES MIROTUBULE; APOPTOSE; CATASTROFE MITOTICA |
| 158/222 | US=92 / Biol/Mol Deininger M. Established cancer therapies: tyrosine kinase inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 477-508. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TERAPIA-ALVO; BCR-ABL; FLT3; EGFR; TYROSISE INIBITORS QUINASE; IMATINIB; GEFITINIB; ERLOTINIB; CANCER; LEUCEMIA |
| 159/222 | US=92 / Biol/Mol Furman RR, Leonard JP, Decter J, Coleman M. Recent and developing cancer therapies: monoclonal antibodies in lymphomas. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 511-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 160/222 | US=92 / Biol/Mol Doll JA, Hobbs JE, Soff GA. Recent and developing cancer therapies: role of apoptosis in anti-angiogenic cancer therapies. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 537-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ANGIOGENESE; APOPTOSE; THROMBOSPONDIN-1; CELULAS ENDOTELIAIS; ANTI-ANGIOGENICO |